For example, mutations in some essential genes, such as TP53 [37] and IDH1/2 [38, 39], are distributed equally between AML cells with miR-182 promoter hypermethylation and hypomethylation (Table S1). This evidence concerns the gene IDH1 and acute myeloid leukemia.